MagSense® Pre-Clinical Safety Data from AACR 2018
May 18, 2018
Pre-clinical data on Imagion Biosystems’ MagSense HER2+ cancer detection platform have shown: specific binding and detection of HER2+ tumor cells in vitro specific detection of